Related references
Note: Only part of the references are listed.Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
A Systematic Approach to Defining the microRNA Landscape in Metastasis
Giridhar Mudduluru et al.
CANCER RESEARCH (2015)
Function and significance of MicroRNAs in benign and malignant human stem cells
Jochen Utikal et al.
SEMINARS IN CANCER BIOLOGY (2015)
MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins
Yongtao Gao et al.
FEBS LETTERS (2015)
miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence
Mitsuhiko Osaki et al.
THERAPEUTIC DELIVERY (2015)
miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC)
Wu Yungang et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion
S. Khosravi et al.
BRITISH JOURNAL OF CANCER (2014)
MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG
Xiao-Ping Chen et al.
CANCER LETTERS (2014)
Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma
Y. Zhang et al.
CELL DEATH AND DIFFERENTIATION (2014)
MiR-134/487b/655 Cluster Regulates TGF-β-Induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells
Kazuhiro Kitamura et al.
MOLECULAR CANCER THERAPEUTICS (2014)
MicroRNAs in colorectal cancer as markers and targets: Recent advances
Jing-Jia Ye et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types
Carolyn D. Britten
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis
Leonidas Benetatos et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Hepatocyte Nuclear Factor-4a Reverses Malignancy of Hepatocellular Carcinoma Through Regulating miR-134 in the DLK1-DIO3 Region
Chuan Yin et al.
HEPATOLOGY (2013)
Perturbation of MicroRNA-370/Lin-28 Homolog A/Nuclear Factor Kappa B Regulatory Circuit Contributes to the Development of Hepatocellular Carcinoma
Wen-Ping Xu et al.
HEPATOLOGY (2013)
MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma
Aaron L. Sarver et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis
Jens Neumann et al.
VIRCHOWS ARCHIV (2013)
The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
Toshio Shimizu et al.
CLINICAL CANCER RESEARCH (2012)
Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas
Giorgia Migliardi et al.
CLINICAL CANCER RESEARCH (2012)
miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells
Jipeng Li et al.
FEBS LETTERS (2012)
The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia
Xiaolu Zhang et al.
MOLECULAR CANCER (2012)
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
James A. McCubrey et al.
ONCOTARGET (2012)
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
Linda S. Steelman et al.
AGING-US (2011)
Therapeutic Resistance Resulting From Mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Signaling Pathways
James A. McCubrey et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
V. Serra et al.
ONCOGENE (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31
Florian Haller et al.
JOURNAL OF PATHOLOGY (2010)
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Wendy De Roock et al.
LANCET ONCOLOGY (2010)
Functional proteomics to dissect tyrosine kinase signalling pathways in cancer
Walter Kolch et al.
NATURE REVIEWS CANCER (2010)
Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis
Elena I. Deryugina et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
Arkaitz Carracedo et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Class IPI3K in oncogenic cellular transformation
L. Zhao et al.
ONCOGENE (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition
S. Meloche et al.
ONCOGENE (2007)
Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis
Jing Wang et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The epidermal growth factor receptor pathway: A model for targeted therapy
Maurizio Scaltriti et al.
CLINICAL CANCER RESEARCH (2006)
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives
JP Spano et al.
ANNALS OF ONCOLOGY (2005)
A comprehensive pathway map of epidermal growth factor receptor signaling
Kanae Oda et al.
MOLECULAR SYSTEMS BIOLOGY (2005)
Impact of EGFR expression on colorectal cancer patient prognosis and survival
JP Spano et al.
ANNALS OF ONCOLOGY (2005)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
MicroRNA maturation: stepwise processing and subcellular localization
Y Lee et al.
EMBO JOURNAL (2002)
Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2. ERB B3) in colorectal adenocarcinomas and adenomas
I Porebska et al.
TUMOR BIOLOGY (2000)
Share Paper
